## Abstract ## Background. The aims of this study were to analyze how age affects treatment and treatment outcome, and to determine whether tumor characteristics differ between different age groups with laryngeal cancer. ## Methods. Patients with laryngeal cancer during 1978–2004 in the Uppsala–
MicroRNA epigenetic alterations in human cancer: One step forward in diagnosis and treatment
✍ Scribed by Nuo Yang; George Coukos; Lin Zhang
- Publisher
- John Wiley and Sons
- Year
- 2007
- Tongue
- French
- Weight
- 189 KB
- Volume
- 122
- Category
- Article
- ISSN
- 0020-7136
No coin nor oath required. For personal study only.
✦ Synopsis
Abstract
MicroRNAs (miRNAs) are approximately 22 nt non‐coding RNAs, which regulate gene expression in a sequence‐specific manner via translational inhibition or messenger RNA (mRNA) degradation. Since the discovery of their fundamental mechanisms of action, the field of miRNAs has opened a new era in the understanding of small noncoding RNAs. By molecular cloning and bioinformatic approaches, miRNAs have been identified in viruses, plants and animals. miRNAs are predicted to negatively target up to one‐third of human mRNAs. Cancer is a complex genetic disease caused by abnormalities in gene structure and expression. Previous studies have heavily focused on protein‐coding genes; however, accumulating evidence is revealing an important role of miRNAs in cancer. Epigenetics is defined as mitotically and/or meiotically heritable changes in gene expression that are not accompanied by changes in DNA sequence. Given the critical roles of miRNAs and epigenetics in cancer, characterizing the epigenetic regulation of miRNAs will provide novel opportunities for the development of cancer biomarkers and/or the identification of new therapeutic targets in the foreseeable future. © 2007 Wiley‐Liss, Inc.
📜 SIMILAR VOLUMES
## Abstract Allelic imbalance (AI) on chromosome arm 22q has been detected in 20%–40% of colorectal cancers, suggesting that this chromosome arm has a tumor‐suppressor gene involved in colorectal carcinogenesis. Recently, we isolated a candidate tumor‐suppressor gene, __MYO18B__, at 22q12.1, that i
## Abstract ## Background Cancer cachexia is a debilitating, wasting condition that affects many cancer patients, including those with head and neck cancer. The overall incidence of cancer cachexia is quite high for some types of cancer, and cachexia will be the main cause of death for more than 2
## Background: Targeting epigenetic events associated with autonomous growth of advanced prostate cancer (pca) is a practical approach for its control, prevention, and treatment. recently we showed that treatment of prostate carcinoma du145 cells with cancer preventive flavonoid silymarin at 100-20
## Abstract ## Background The use of a single MRI and 18F‐fluoro deoxyglucose positron emission tomography‐CT (18F‐FDG PET‐CT) was evaluated, both in diagnostic procedure and radiotherapy planning, in patients with head and neck cancer. ## Methods Thirty‐five patients with nasopharyngeal and oro